Three Compounds, Three Different Evidence Stories: What Semaglutide, Tirzepatide and AOD-9604 Reveal About the Gap Between Scientific Research, Clinical Trials and FDA Approval

Three compounds can appear in the same discussion about peptide science while carrying very different levels of medical evidence. Semaglutide has been studied extensively in humans and is the active ingredient in several FDA-approved medici

The Laboratory Experiment That Made a Compound Look Promising, Until Researchers Asked Whether the Result Could Ever Translate Into Human Health

A laboratory result can be accurate, repeatable and scientifically interesting without telling researchers whether a compound will ever benefit a patient. That distinction gets lost when an early experiment produces an attractive graph, a s

The Reagent Lot Changed, Not the Protocol: Why a Repeat Experiment Can Produce a Different Result Six Months Later Copy headline

Six months ago, an experimental readout looked consistent. The laboratory recorded its method, retained the instrument files, and documented the material it had used. Now the team repeats the work with a newly delivered lot of the same name

Quick Read

Treatments and Symptoms

Science Trends

Latest Articles